Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Revenue

In the fiscal year ending November 30, 2025, Heidelberg Pharma AG had annual revenue of 1.46M EUR, down -78.72%. Heidelberg Pharma AG had revenue of 21.44K in the quarter ending November 30, 2025, a decrease of -98.66%.

• Revenue: 1.46M
• Revenue Growth: -78.72%
• P/S Ratio: 88.28
• Revenue / Employee: 12.78K
• Employees: 114
• Market Cap: 128.66M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2025	1.46M	-5.39M	-78.72%
Nov 30, 2024	6.85M	-3.01M	-30.53%
Nov 30, 2023	9.86M	-8.66M	-46.75%
Nov 30, 2022	18.51M	16.48M	810.30%
Nov 30, 2021	2.03M	-6.63M	-76.53%